The current RPRX market cap is 18.33B. The company's latest EPS is USD 1.8995 and P/E is 15.99.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 617.71M | 467.76M | 683.97M | 653.4M | 543.61M |
Operating Income | 233.2M | 28.33M | 513.58M | 363.27M | 153.52M |
Net Income | 142.65M | -456.08M | 340.76M | 227.63M | 72.11M |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 2.12B | 2.29B | 2.24B | 2.35B |
Operating Income | -13.79M | 1.64B | 1.41B | 913.92M | 1.5B |
Net Income | 51.28M | 975.04M | 619.73M | 42.83M | 1.13B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 17.67B | 16.81B | 17.07B | 17.12B | 15.86B |
Total Liabilities | 7.26B | 7.29B | 7.25B | 7.31B | 6.27B |
Total Equity | 10.42B | 9.53B | 9.82B | 9.81B | 9.59B |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 15.07B | 16.02B | 17.52B | 16.81B | 16.38B |
Total Liabilities | 10.03M | 6.12B | 7.27B | 7.29B | 6.3B |
Total Equity | 15.06B | 9.9B | 10.25B | 9.53B | 10.08B |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.57B | 2.14B | 1.03B | 1.64B | 2.22B |
Investing | -1.44B | -1.03B | -558.53M | -621.96M | -1.07B |
Financing | -679.31M | -944.86M | -210.37M | -557.37M | -1.92B |
Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 45.61M | 2.03B | 2.02B | 2.14B | 2.99B |
Investing | -1.87B | -2.76B | -1.87B | -1.03B | -2.07B |
Financing | 1.91B | 1.49B | 385.11M | -944.86M | -2.15B |
Market Cap | 18.33B |
Price to Earnings Ratio | 15.99 |
Price to Sales Ratio | 7.71 |
Price to Cash Ratio | 38.05 |
Price to Book Ratio | 1.8 |
Dividend Yield | 2.64% |
Shares Outstanding | 597.43M |
Average Volume (1 week) | 1.61M |
Average Volume (1 Month) | 2.4M |
52 Week Change | -17.39% |
52 Week High | 37.42 |
52 Week Low | 25.92 |
Spread (Intraday) | 0.32 (1.03%) |
Company Name | Royalty Pharma PLC |
Address |
the pavilions bridgwater road bristol BS13 8AE |
Website | https://www.royaltypharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.